Paragon-backed Apontis Pharma announces IPO intention


Pharmaceutical business Apontis Pharma, a portfolio company of Paragon Partners, has announced its intention to float on the Frankfurt Stock Exchange in Q2 2021.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *